Loading...
Please wait, while we are loading the content...
Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician
| Content Provider | Scilit |
|---|---|
| Author | Findeisen, Kate E. Sewell, Julia Ostor, Andrew Jk |
| Copyright Year | 2021 |
| Description | Journal: Biologics: Targets and Therapy Rheumatoid arthritis (RA) is a disease characterised by inflammation of synovial joints and poses a substantial healthcare burden on both the individual and society. One of the most significant shifts in the RA therapeutic landscape has occurred with the introduction of biological disease modifying anti-rheumatic drugs (bDMARDs). There are five classes of bDMARDs currently available, each with a different molecular target and subtle differences in their efficacy and safety profile. This review also describes the “real-world” use of bDMARDs and how they fit into the overall RA treatment guidelines. |
| Related Links | https://www.dovepress.com/getfile.php?fileID=72575 |
| Ending Page | 352 |
| Page Count | 10 |
| Starting Page | 343 |
| ISSN | 11775475 |
| e-ISSN | 11775475 |
| DOI | 10.2147/btt.s252575 |
| Journal | Biologics: Targets and Therapy |
| Volume Number | ume 15 |
| Language | English |
| Publisher | Informa UK Limited |
| Publisher Date | 2021-08-01 |
| Access Restriction | Open |
| Subject Keyword | Journal: Biologics: Targets and Therapy Rheumatoid Arthritis Biological Therapies |
| Content Type | Text |
| Subject | Immunology and Allergy Gastroenterology Pharmacology (medical) Rheumatology Oncology |